Extraintestinal pathogenic Escherichia coli (ExPEC) strains are the cause of most community and hospitalacquired extraintestinal E. coli infections, including infections of the urinary tract, bloodstream, and other anatomical sites [1] . ExPEC include neonatal meningitis E. coli and uropathogenic E. coli. During the past 10 years, recognition has grown that certain important E. coli lineages, or clonal groups (defined as genetically closely related E. coli isolates), are responsible for a large fraction of human extraintestinal E. coli infections and that these lineages are variably antimicrobial resistant.
Molecular epidemiology studies of ExPEC from around the world have identified several potential reservoirs for ExPEC, including the human intestinal tract, plus various nonhuman reservoirs such as food animals and retail meat products, sewage and other environmental sources, and companion animals. Here we review the evidence for food and food animal reservoirs for human ExPEC, paying specific attention to those ExPEC lineages that cause a large fraction of infections and to the public health implications and importance of food animal reservoirs for ExPEC dissemination and transmission.
FOOD-BORNE ORIGINS OF HUMAN ExPEC
Much current research effort is directed toward determining the contribution, if any, to human infections of food animal-associated ExPEC, particularly those strains that are resistant to therapeutically important antimicrobials. Based on existing evidence, poultry is the food animal source most closely linked to human ExPEC [2] [3] [4] [5] [6] [7] [8] [9] . Poultry meat exhibits the highest overall levels of E. coli contamination, and these E. coli can be more extensively antimicrobial resistant than E. coli recovered from other meats [10, 11] . Poultry-associated E. coli also often possess virulence genes similar to those of human ExPEC, suggesting the potential to cause human disease. Contamination of pork with ExPEC has also been reported; however, fewer studies have been conducted to date [3, 8, [12] [13] [14] .
Investigators of the human versus extrahuman origins of ExPEC have used both population ecology surveys and experimental pathogenesis studies to examine the host species distribution and ExPEC specificity. What has emerged is a picture of a large and complex group of E. coli variants, within which a small number of highly successful lineages (in terms of virulence and geographic range) have become established and account for the bulk of extraintestinal E. coli infections in humans and some domestic animals. More importantly, these extraintestinal disease-causing lineages are becoming increasingly multidrug resistant and, therefore, difficult to treat. Identification of sources or potential reservoirs for these important human-associated ExPEC groups could help to curb their transmission, or, at the very least, to reduce the extent of antimicrobial resistance associated with human ExPEC infections.
One hypothesis that has emerged is that some humanassociated ExPEC evolved from, or are the same as, avian pathogenic E. coli (APEC), the cause of colibacillosis, an extraintestinal infection in poultry. Extensive genetic similarity has been documented between APEC and ExPEC strains causing disease in poultry and humans, respectively [15] [16] [17] [18] [19] [20] . Experimental evidence suggests that APEC can cause disease in mammalian infection models that mimic human ExPEC infections (eg, ascending urinary tract infection [UTI]) [12, 21] ; conversely, human-source ExPEC can cause disease in avian disease models [22, 23] .
A possible link between human-associated ExPEC and APEC, or E. coli derived from poultry, especially chicken, is further supported by the commonality of antimicrobial resistance patterns and/or resistance genes among E. coli from these sources [2, 3, 5, 6, 9, 24] , and by an epidemiologic association among women with UTI between self-reported chicken consumption and having an antimicrobial-resistant UTI pathogen [8] . Recent studies have identified highly similar extendedspectrum β-lactamase (ESBL)-producing E. coli strains in humans and retail chicken products [7, 9] . Likewise, APEC and human-associated ExPEC have been shown to possess overlapping virulence and antimicrobial resistance gene profiles [16, 17, 18, 20, 22, 25] . The minor genetic differences observed between the 2 source groups could be related to recent evolutionary changes associated with host specificity [26] .
A likely factor underlying the observed emergence of antimicrobial-resistant E. coli strains resembling human ExPEC in food animals, especially poultry, is the disproportionate increase in human consumption of retail chicken during the past 30 years [27] . This has led to changes in the scale and methods of food animal production, including increased use of antimicrobial agents for growth promotion, feed efficiency, infection prevention, and treatment [28] . Multiple lines of evidence indicate that these changes have helped to select for and amplify multidrug-resistant ExPEC [29] . Resistant E. coli, once established in food animal reservoirs, can spread among animals, maintaining the circulation of drug-resistant ExPEC in food animals [29] .
The proposed chain of food-borne ExPEC transmission postulates that ExPEC originating from food animals or meat products subclinically colonize the human consumer's intestinal tract and reside there until circumstances favor an extraintestinal infection (eg, sexual intercourse or urinary catheter insertion). The host's own intestinal tract is the conventionally recognized source of the ExPEC that cause human infections [30, 31] . Once an incoming ExPEC strain establishes residence in the intestinal tract, it will be available to cause disease in the subsequent months [32] . The often-lengthy interval between ExPEC acquisition and disease development (if disease even occurs) makes transmission of ExPEC and antimicrobial-resistant E. coli from external (eg, food-source) reservoirs to humans difficult to detect.
DEFINING ExPEC LINEAGES
The labels applied to important ExPEC groups have evolved over the decades in relation to the technologies used to identify these groups. Early studies identified 10-15 O antigenbased serogroups (of the approximately 180 that occur in E. coli) as being associated with human extraintestinal infections [26, 33] . The addition of K and H antigen typing, resolved more highly homogeneous groups. Recent DNAbased genotyping methods such as multilocus sequence typing (MLST) have further advanced our understanding of these lineages. For consistency, we use labels that combine the group's O:K:H serotype (if known), major E. coli phylogenetic group of origin (A, B1, B2, or D), and sequence type (ST), as determined by MLST (for example, O25:H4-B2-ST131). MLST is widely used today to resolve ExPEC lineages because it captures evolutionary relationships among E. coli groups and provides consistent results that are easily comparable across laboratories [34] . Although MLST is not as highly discriminatory as certain other genotyping methods, it is useful for regional or global molecular epidemiology studies.
EMERGING ExPEC LINEAGES
We focus on specific lineages of ExPEC, characterized by MLST, that in population-based studies appear to be collectively responsible for a large fraction of human extraintestinal infections. Because many of these groups have come to attention through surveys specifically focused on ESBL-producing E. coli, ESBL-producing lineages are overrepresented. Evidence for food reservoirs and transmission routes are presented for each major group, and a summary is provided in Table 1 .
Initially reported in 2008 as an important new pathogen [35, 36] , E. coli O25:H4-B2-ST131 is a globally emerging lineage of E. coli. It is currently under intense investigation because of its extensive antimicrobial resistance profile, which often includes ESBL production, specifically of CTX-M-15, plus fluoroquinolone resistance. O25:H4-B2-ST131 has been identified primarily from human infections and has been associated with travel, possibly explaining its widespread emergence during the past decade. In surveys of human E. coli infections this group accounts for a large fraction of cases overall [37] , and up to 88% of antimicrobial-resistant infections, depending on the specific resistance phenotype [38, 39] .
Nonhuman intestinal carriage of this group has been reported for wild, companion, and food animals, although the prevalence of human colonization has tended to exceed that of nonhuman animal colonization, as recently reviewed [39, 40] . Indistinguishable E. coli O25:H4-B2-ST131 strains have been identified in a human UTI case and retail chicken meat sample in Canada [14] . Mora et al also demonstrated similarity by pulsed field gel electrophoresis (PFGE) and virulence gene content between 1 chicken and 1 human E. coli O25:H4-B2-ST131 isolate [41] . ESBL-positive E. coli O25:H4-B2-ST131 was also recovered from poultry farms in Spain, with human and poultry O25:H4-B2-ST131 isolates exhibiting moderate (75%) PFGE similarity [42] . Two other studies identified ESBL-positive ST131 E. coli among humans but not in chickens or chicken meat [7, 9] . E. coli ST131 has been detected in pork and UTI isolates from Denmark and Norway [43] .
E. coli O11/O17/O77:K52:H18-D-ST69 E. coli O11/O17/O77:K52:H18-D-ST69 (also termed CgA, for "clonal group A"), members of which express various closely related O antigens, was identified initially in an apparent outbreak of extraintestinal infections in Berkeley, California, during which it accounted for 11% of all UTIs and 52% of antimicrobial-resistant UTIs [44] . It subsequently has been identified around the world, usually as a cause of sporadic human disease [45] . This group often exhibits multidrug resistance and has been responsible for urinary tract and more severe human extraintestinal infections [38, [45] [46] [47] . Several studies have confirmed this group as a cause of about 10%-20% of all human E. coli infections [45, 48, 49] . A recent global survey suggested that the O11/O17/O77:K52:H18-D-ST69 group is concentrated in North America and may have emerged in the 1990s [49] . O11/O17/O77:K52:H18-D-ST69 has been linked to nonhuman reservoirs, primarily pork and chicken [12, 14] , and possibly beef [50] . In an experimental study, CgA E. coli isolates recovered in Denmark from human infections and retail chicken meat were equally able to cause UTI in a mouse model, suggesting that food animal-source CgA E. coli are just as pathogenic as human-derived CgA strains [2] .
E. coli Serotype (Various)-A-ST10
The E. coli ST10 clonal complex (ie, ST10 and closely related STs), although commonly encountered as an antimicrobialsusceptible, low-virulence human intestinal colonizer, also has been associated with human infections and ESBL production, including as isolated from human clinical specimens (from hospital and community-acquired infections), meat products, and food animals [42, [51] [52] [53] . Specifically, in 1 study from the Netherlands, CTX-M-1-producing ST10 isolates were identified in human blood cultures and poultry, whereas TEM-52-producing ST10 isolates were recovered from human urine samples and poultry [7] . Likewise, a similar study from the Netherlands identified ESBL-producing E. coli ST10 in chicken meat, other meat types, rectal swab samples from healthy humans, and human blood cultures [9] . Moreover, a study from Canada identified multidrug-resistant ST10 isolates (albeit of limited PFGE similarity) in human clinical samples, chicken and pig feces, and retail chicken and pork meat [54] .
E. coli Serotype (Various)-D-ST117
E. coli ST117 is a recognized APEC lineage [18] . One study identified a human sepsis-associated O111:H4-D-ST117 ExPEC strain that resembled known APEC strains [18] . Likewise, the 2 above-mentioned studies from the Netherlands linking E. coli ST10 isolates from human and poultry reservoirs also identified ESBL-producing ST117 E. coli in these reservoirs [7, 9] . Closely related O114:H4-ST117 strains also have been identified in a human UTI case and in retail chicken meat in Canada [14] .
E. coli O1/O2/O18:K1:H7-B2-ST95
E. coli O1/O2/O18:K1:H7-B2-ST95, a recognized APEC clonal group [55] and prominent human pathogen, caused 6% of human extraintestinal infections in 1 study [56] . E. coli O1/O2/ O18:K1:H7-B2-ST95 isolates with related PFGE profiles have been identified in humans and poultry [14, 17] and, separately, in honeydew melon and multiple human infections [14] . In another study, within a cluster of 108 APEC and human ExPEC isolates from serogroups O1, O2, or O18, 58% of isolates, representing diverse host species, belonged to ST95 [25] . When assessed in animal models, O18-B2-ST95 E. coli isolates from human neonates with meningitis could cause colisepticemia in poultry [22] ; conversely, O18-B2-ST95 E. coli isolates from cases of avian colibacillosis (APEC) could cause neonatal meningitis in a rat model [21] . This indicated that the APECand neonatal meningitis E. coli-associated ST95 group may have zoonotic potential.
OTHER IMPORTANT HUMAN ExPEC GROUPS WITHOUT KNOWN FOOD ANIMAL ASSOCIATIONS
E. coli O15:K52:H1-D-ST393 was first recognized during an outbreak of extraintestinal infections in 1986-1987 in London, United Kingdom [57] , and has since been identified elsewhere in Europe [58, 59] and globally [60] . In the initial epidemic, O15:K52:H1 caused 26% of all extraintestinal infections during a 1-year interval [37, 57] . This group is typically multidrug resistant and has caused community-acquired extraintestinal infections of all types [57, 59, 61, 62] . No available evidence supports the existence of food animal reservoirs for O15:K52: H1-ST393, and investigations during the London outbreak failed to identify a source [63] . This group is closely related to O11/O17/O77:K52:H18-D-ST69; both groups commonly possess similar antimicrobial resistance and virulence factor patterns and appear to share a common ancestor [63, 64] .
E. coli O6:H1-B2-ST73 was recently reported as a leading cause (17% overall) of human extraintestinal infections in the UK [56] . This group, like many others, is associated occasionally with ESBL production [56, 65, 66] . It may represent a long-standing, human-adapted ExPEC group, because it has caused UTIs in women from widely separated geographic areas over many years [67] . To date, no food animal reservoirs for this group have been reported. E. coli serotype (Various)-D-ST405 is another globally disseminated, extensively antimicrobial-resistant group [35] . ST405 may be the second most common contributor to the global dissemination of CTX-M-15 after ST131 [35] . Furthermore, an ST405 E. coli isolate was recently encountered that produced multiple ESBLs, including QepA1, CTX-M-15, and RmtB [68] . ST405 has been associated with person-to-person transmission in 1 study [69] . Evidence for nonhuman reservoirs is still lacking, suggesting that this group also may exist exclusively among humans [67] .
E. coli O75:K + :H5-B2-ST14, a historically important ampicillin-resistant group, has recently been associated with fluoroquinolone resistance in Australia [70] . Although this group recently has been identified in pet dogs, no food or food animal reservoir has yet been demonstrated [70] .
Accumulating evidence indicates that certain prominent ExPEC groups can occur in nonhuman sources, including food animals and retail meat products, although the extent of this phenomenon, its importance to human health, and the strength of the evidence vary by source and E. coli group.
These major lineages are implicated repeatedly as causing a large proportion of human extraintestinal infections. Since many are multidrug resistant, they probably contribute significantly to the ongoing population-level increase in antimicrobial-resistant human E. coli infections. For example, in a recent study, just 3 clonal groups (O25:H4-B2-ST131, O15:H1-D-ST393, and O11/O17/O77:K52:H18-D-ST69) accounted for 19% of 500 consecutive extraintestinal E. coli isolates in 5 hospitals in Spain, and for 30% of multidrug-resistant isolates [38] .
Similarities between human ExPEC and E. coli recovered from poultry and pigs, and from retail chicken, turkey, and pork products, suggest a possible role for a food animal reservoir. Although transmission of ExPEC has been documented between cohabiting humans and between companion animals and humans [32, [71] [72] [73] [74] , transmission of ExPEC from food animals or retail meats to humans has yet to be directly demonstrated. However, members of at least 4 of the abovementioned high-prevalence ExPEC groups have been identified in nonhuman reservoirs, with the main such source being food animals, specifically chickens and pigs.
Additionally, the plausibility of food-borne transmission of antimicrobial-resistant E. coli to humans is supported by the finding that antimicrobial-resistant E. coli from chicken carcasses widely contaminate the kitchen during meal preparation and can appear in the intestinal tract of individuals who prepare food dishes from the carcasses [75, 76] . Furthermore, volunteers fed a diet of irradiated food exhibited markedly reduced levels of antimicrobial-resistant intestinal E. coli, with reversion to baseline after intervention [77] , implying that a conventional diet sustains the baseline prevalence of intestinal resistant E. coli through a steady input of food-borne resistant organisms. Thus, the available evidence, albeit indirect, strongly supports a food-borne component to the antimicrobial-resistant E. coli problem in humans.
The above-mentioned food-animal-associated ExPEC groups typically exhibit multidrug resistance. This probably occurs because they and other animal-associated E. coli are subjected to frequent or continuous selection pressure for antimicrobial resistance within the food animal reservoir, due to extensive antimicrobial use during food animal production [78] . Human antimicrobial use provides additional selection pressure once these organisms enter the human population. Thus, the global increase of antimicrobial resistance among human-associated ExPEC likely has multiple ecologic origins, with contributions from the transmission of antimicrobial resistant ExPEC from food animals, companion animals, and environmental sources to humans after amplification in these selection reservoirs, followed by further amplification in humans [79] .
From [80] . However, given the linkage of multiple resistance genes and the inescapable need for antimicrobial use in some circumstances, in humans and animals alike, stewardship may at best be a harm reduction strategy, slowing rather than preventing further emergence and spread of resistant E. coli. Recent efforts have focused on eliminating or reducing the food production use of antimicrobials classified as very important to human medicine (eg, 3rd generation cephalosporins) [81] to reduce antimicrobial resistance, but this is not always a straightforward or successful approach (eg, the ban on fluoroquinolone use in poultry) [82] . Reducing E. coli contamination levels on meat products is another possible intervention.
Another preventive approach deserving consideration is vaccines. Food animal-associated ExPEC lineages possess virulence properties that contribute to their ability to cause extraintestinal disease, in humans and animals alike. They also must have characteristics promoting their survival within specific reservoirs (eg, in avian hosts) and widespread dissemination among human hosts. Indeed, distinguishing between genes associated with "virulence"-versus "fitness" and versus "colonization"-can be difficult [83] . Whereas some ExPEC lineages can be traced far back in time and are well established as perennial extraintestinal pathogens [37] , new ExPEC lineages continuously emerge [84] . Elucidation of the factors that make certain ExPEC groups so successful could identify good candidate vaccine targets, which could be particularly suitable for use in the animal hosts that act as reservoirs [85] .
It is important to elucidate the transmission dynamics of the main recognized ExPEC groups, which are key contributors to human extraintestinal E. coli disease. Understanding these organisms' reservoirs, chain of transmission, and epidemiologic associations will go a long way toward finding ways to reduce the associated disease burden. There are inherent limitations to ecologic studies comparing ExPEC from multiple sources. Determining the direction of transmission (from animals to human or vice versa) and pinpointing actual transmission events has been difficult. However, despite these limitations, the greater public health community should heed the growing body of evidence supporting food-borne transmission, and should implement policies and practices that would meaningfully limit the evolution, selection and amplification, and dissemination of antimicrobial-resistant ExPEC from food animals to humans. This table summarizes general information available on these groups from the literature. It is not exhaustive and does not distinguish the quantity or quality of the data.
Notes
Abbreviations: ESBL; extended-spectrum β-lactamase; ExPEC, extraintestinal pathogenic Escherichia coli. a Many E. coli ST10 strains are not ExPEC; those that are ExPEC tend to be extensively antimicrobial resistant.
